Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Forner

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
European Radiology|August 3, 2019
Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinomaJordi Rimola, Alejandro Forner, Víctor Sapena, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 6, 2019
Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical PatientsÁlvaro Díaz-González, Ramón Vilana, Luis Bianchi, et al.
AJR. American Journal of Roentgenology|June 25, 2013
Consensus report of the Fifth International Forum for Liver MRIChristoph J Zech, Carlo Bartolozzi, Paulette Bioulac-Sage, et al.
Journal of Hepatology|June 25, 2021
Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survivalJoana Ferrer-Fàbrega, Jaime Sampson-Dávila, Alejandro Forner, et al.
Cancers|January 27, 2021
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular CarcinomaJosep Corominas, Victor Sapena, Marco Sanduzzi-Zamparelli, et al.
Frontiers in Immunology|February 23, 2026
Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stagesCarla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Oncotarget|March 22, 2021
Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activityLeonardo G da Fonseca, Carla Fuster-Anglada, Cristina Carrera, et al.
Frontiers in Immunology|June 23, 2025
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stagesCarla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Journal of Clinical Gastroenterology|June 13, 2020
Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular CarcinomaÁlvaro Díaz-González, Ernest Belmonte, Víctor Sapena, et al.
Medicina Clinica|March 15, 2016
[Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH]Alejandro Forner, María Reig, María Varela, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
European Radiology|August 3, 2019
Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinomaJordi Rimola, Alejandro Forner, Víctor Sapena, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 6, 2019
Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical PatientsÁlvaro Díaz-González, Ramón Vilana, Luis Bianchi, et al.
AJR. American Journal of Roentgenology|June 25, 2013
Consensus report of the Fifth International Forum for Liver MRIChristoph J Zech, Carlo Bartolozzi, Paulette Bioulac-Sage, et al.
Journal of Hepatology|June 25, 2021
Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survivalJoana Ferrer-Fàbrega, Jaime Sampson-Dávila, Alejandro Forner, et al.
Cancers|January 27, 2021
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular CarcinomaJosep Corominas, Victor Sapena, Marco Sanduzzi-Zamparelli, et al.
Frontiers in Immunology|February 23, 2026
Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stagesCarla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Oncotarget|March 22, 2021
Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activityLeonardo G da Fonseca, Carla Fuster-Anglada, Cristina Carrera, et al.
Frontiers in Immunology|June 23, 2025
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stagesCarla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Journal of Clinical Gastroenterology|June 13, 2020
Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular CarcinomaÁlvaro Díaz-González, Ernest Belmonte, Víctor Sapena, et al.
Medicina Clinica|March 15, 2016
[Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH]Alejandro Forner, María Reig, María Varela, et al.
Pageof 11